Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000625199 | SCV000744106 | likely benign | Hypertrophic cardiomyopathy 17 | 2015-09-21 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003162763 | SCV003856132 | likely benign | Cardiovascular phenotype | 2022-12-04 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Labcorp Genetics |
RCV003586212 | SCV004324219 | likely benign | Hypertrophic cardiomyopathy | 2023-08-30 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001701126 | SCV001919229 | benign | not specified | no assertion criteria provided | clinical testing | ||
Joint Genome Diagnostic Labs from Nijmegen and Maastricht, |
RCV001724103 | SCV001957288 | likely benign | not provided | no assertion criteria provided | clinical testing |